Oliver Appelhans is head of the European Specialty Business Unit. He is a chemist by education and joined Daiichi Sankyo in 2007 after a successful career at AstraZeneca. At Daiichi Sankyo, he has had numerous roles at both the German and the European organisation, including European launch lead, managing director of the German organisation and most recently he was head of commercial operations Europe and partner management.
